Evidence map›Paper›PMID 19242554›Full record

Trial reportPloS one2009

Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study.

Giorgos K Sakkas, Kathleen Mulligan, Makani Dasilva, Julie W Doyle, Hootan Khatami, Thomas Schleich, Jane A Kent-Braun, Morris Schambelan

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00484627 (Ergogenic Effects of Creatine Supplementation in HIV Infection), which is not on this map. Cited by 13 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 5 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00484627 phase2completednot on this map

Ergogenic Effects of Creatine Supplementation in HIV Infection

TypeinterventionalSponsorNational Center for Complementary and Integrative Health (NCCIH)Ran2001 to 2003Enrolled43ConditionsHIV InfectionsArmsUse of creatine monohydrate (a dietary supplement), Progressive resistance exercise training
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 5 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Nutritional recommendations for the management of sarcopenia.Journal of the American Medical Directors Association · 2010
    Review
  13. Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting?Current opinion in clinical nutrition and metabolic care · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Giorgos K SakkasDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Kathleen Mulligan
Makani Dasilva
Julie W Doyle
Hootan Khatami
Thomas Schleich
Jane A Kent-Braun
Morris Schambelan
San Francisco General Hospital · USNorthern California Institute for Research and Education · USUniversity of California, San Francisco · USUniversity of California, Santa Cruz · USUniversity of Massachusetts Amherst · USUniversity of Thessaly · GR

Funding

WELFARE REFORM AND THE PERINATAL HEALTH OF IMMIGRANTSM01RR000083 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KESSLER, DAVID A · 1985 to 2006
$21.1M
METABOLIC EFFECTS OF PROTEASE INHIBITORS IN HIV DISEASER01DK054615 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI MULLIGAN, KATHLEEN · 1998 to 2002
$1.0M
Ergogenic Effects of Creatine Supp .in HIV-Assoc.WastingR01AT000491 · NCCIH · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI SCHAMBELAN, MORRIS · 2000 to 2002
$788k
ANABOLIC THERAPIES AND THEIR METABOLIC EFFECTS IN AIDSR01DK045833 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI SCHAMBELAN, MORRIS · 1992 to 2002
$713k
NCCIH NIH HHS AT00491NCCIH NIH HHS R01 AT000491NCRR NIH HHS M01 RR000083NCRR NIH HHS RR-00083NIDDK NIH HHS DK45833NIDDK NIH HHS DK54615NIDDK NIH HHS R01 DK054615
6 · The paper itself

Abstract

backgroundProgressive resistance exercise training (PRT) improves physical functioning in patients with HIV infection. Creatine supplementation can augment the benefits derived from training in athletes and improve muscle function in patients with muscle wasting. The objective of this study was to determine whether creatine supplementation augments the effects of PRT on muscle strength, energetics, and body composition in HIV-infected patients. METHODOLOGY/PRINCIPAL

findingsThis is a randomized, double blind, placebo-controlled, clinical research center-based, outpatient study in San Francisco. 40 HIV-positive men (20 creatine, 20 placebo) enrolled in a 14-week study. Subjects were randomly assigned to receive creatine monohydrate or placebo for 14 weeks. Treatment began with a loading dose of 20 g/day or an equivalent number of placebo capsules for 5 days, followed by maintenance dosing of 4.8 g/day or placebo. Beginning at week 2 and continuing to week 14, all subjects underwent thrice-weekly supervised resistance exercise while continuing on the assigned study medication (with repeated 6-week cycles of loading and maintenance). The main outcome measurements included muscle strength (one repetition maximum), energetics ((31)P magnetic resonance spectroscopy), composition and size (magnetic resonance imaging), as well as total body composition (dual-energy X-ray absorptiometry). Thirty-three subjects completed the study (17 creatine, 16 placebo). Strength increased in all 8 muscle groups studied following PRT, but this increase was not augmented by creatine supplementation (average increase 44 vs. 42%, difference 2%, 95% CI -9.5% to 13.9%) in creatine and placebo, respectively). There were no differences between groups in changes in muscle energetics. Thigh muscle cross-sectional area increased following resistance exercise, with no additive effect of creatine. Lean body mass (LBM) increased to a significantly greater extent with creatine. CONCLUSIONS / SIGNIFICANCE: Resistance exercise improved muscle size, strength and function in HIV-infected men. While creatine supplementation produced a greater increase in LBM, it did not augment the robust increase in strength derived from PRT.

trial registrationClinicalTrials.gov NCT00484627.

Indexed as

Resistance TrainingAdultBody CompositionCreatineDouble-Blind MethodHIV InfectionsHumansMaleMiddle AgedMuscle StrengthPhysical EnduranceSan FranciscoTreatment OutcomeCreatine

Identifiers

PMID19242554
PMCPMC2646129
OpenAlexW1994952209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.